U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Xeloda versus 5-FU/LV in adjuvant colon cancer: whats your conclusion? David Kerr University of Oxford Oxford, UK.
A Report from ASCO 2007 Adjuvant Colorectal Cancer John L. Marshall, MD Chief, Division of Hematology/Oncology Associate Director of Clinical Research.
Oral Colorectal Presentations: Discussion Abstracts #4009 - #4011 Cathy Eng, M.D. The University of Texas M.D. Anderson Cancer Center May 31, 2008.
A Report from ASCO 2007 Adjuvant Colorectal Cancer
Intravenous calcium and magnesium prevents oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: Results of a phase III placebo-controlled,
Nicholas Petrelli, M.D.
